Michael H. May - 21 Jun 2021 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Role
Director
Signature
/s/Michael H. May
Issuer symbol
SER
Transactions as of
21 Jun 2021
Net transactions value
$0
Form type
4
Filing time
23 Jun 2021, 21:46:27 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Option to Purchase Common Stock Award $0 +65,000 $0.000000 65,000 21 Jun 2021 Common Stock 65,000 $1.48 Direct F1
transaction AGE Option to Purchase Common Stock Award $0 +35,000 $0.000000 35,000 21 Jun 2021 Common Stock 35,000 $1.48 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options will vest and become exercisable in four equal quarterly installments on June 30, 2021, September 30, 2021, December 31, 2021, and March 31, 2022, provided that the grantee remains a director on the last day of the applicable calendar quarter.